<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 16 Jun 2026 07:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical </title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical+/26650422.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical+/26650422.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical </title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical+/26650422.html</link>
   <description>&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical+/26650422.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
  <item>
   <title>FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical</title>
   <link>http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;b&gt;FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical&lt;/b&gt;&lt;/p&gt;  &lt;p&gt;AUSTIN, Texas, June  16, 2026  (GLOBE NEWSWIRE) --  FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand access to Focal One Robotic HIFU (High Intensity Focused Ultrasound) to federal healthcare providers and make its prostate treatment technology available to Veterans and active-duty military personnel throughout the VA and Department of Defense healthcare systems (“Veterans</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/FocalTherics%E2%84%A2+Expands+Access+to+Focal+One%C2%AE+Robotic+HIFU+for+Veterans+with+Prostate+Cancer+through+Agreement+with+MellingMedical/26650450.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14320728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216920</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EDAP</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FOCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00325576</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20250741</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.65300616</category>
   	  </item>
 </channel>
</rss>
